4888 · STELLA PHARMA CORPORATION

394.00

JPY

10.00 (2.60%)

09/10/2026 12:00:00 AM

Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

JPY14.22B

0.00

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

N/A

MQV Rating

5Very Weak

As at 09/10/2026 12:00:00 AM

Price Chart

Description

Stella Pharma Corp. engages in the development, manufacture, and sale of pharmaceuticals. It provides boron-based drugs used for Boron Neutron Capture Therapy (BNCT), a form of radiotherapy that targets cancer cells using biochemical methods. The company was founded on June 1, 2007 and is headquartered in Osaka, Japan.

All-Companies
Big Candle
HALO All

Key Fundamentals

EPS 3 yr Growth

-6.90%

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Performance

52 weeks range

Low 200 - 995

Trade Value (12mth)

US$911,506.00

1 week

-11.11%

1 month

3.78%

YTD

81.13%

1 year

5.79%

All time high

1070.00

Additional Data

Shares Outstanding (Fully Diluted)

35m

HALO Sector

Healthcare

Next Company Report Date

11-May-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

JPY

Short Sell (% of issue)

0.00

Consensus

Unlock full consensus

Consensus score

/10

Recommendation

Buy

Target price

Deviation

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Valuation

Unlock full dataset

Value

Consensus

Yield

News & Announcements

No announcements available.

Key Stakeholders

Name	Title
Stella Chemifa Corp.	Public Company
Takuji Nakamura	Individual
International Club Foundation	Foundation/Endowment
Yoshimi Murakami	Individual
Hideyo Aoyama	Individual